Equity Overview
Price & Market Data
Price: $1.07
Daily Change: +$0.02 / 1.87%
Daily Range: $1.02 - $1.11
Market Cap: $5,275,350
Daily Volume: 8,056
Performance Metrics
1 Week: 10.53%
1 Month: -9.48%
3 Months: -78.16%
6 Months: -93.16%
1 Year: -93.46%
YTD: -80.10%
Details
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.